Cargando…
Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells
PURPOSE: We recently found that the tetraspanin family member, CD82, which is aberrantly expressed in chemotherapy-resistant CD34(+)/CD38(−) acute myelogenous leukemia (AML) cells, negatively regulates matrix metalloproteinase 9, and plays an important role in enabling CD34(+)/CD38(−) AML cells to a...
Autores principales: | Nishioka, Chie, Ikezoe, Takayuki, Yang, Jing, Yokoyama, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425466/ https://www.ncbi.nlm.nih.gov/pubmed/25955299 http://dx.doi.org/10.1371/journal.pone.0125017 |
Ejemplares similares
-
Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo
por: Nishioka, Chie, et al.
Publicado: (2015) -
MicroRNA‐9 plays a role in interleukin‐10‐mediated expression of E‐cadherin in acute myelogenous leukemia cells
por: Nishioka, Chie, et al.
Publicado: (2017) -
Downregulation of miR-217 correlates with resistance of ph(+) leukemia cells to ABL tyrosine kinase inhibitors
por: Nishioka, Chie, et al.
Publicado: (2014) -
Tetraspanin CD82 Regulates the Spatiotemporal Dynamics of PKCα in Acute Myeloid Leukemia
por: Termini, Christina M., et al.
Publicado: (2016) -
Regulation of cytoskeleton and adhesion signaling in osteoclasts by tetraspanin CD82
por: Bergsma, Alexis, et al.
Publicado: (2019)